Alyeska Investment Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Sell
7,074
-294,050
-98% -$61.1M ﹤0.01% 583
2026
Q1
$63.6M Buy
301,124
+81,124
+37% +$17.5M 0.18% 156
2025
Q4
$45.2M Sell
220,000
-489,087
-69% -$92M 0.13% 196
2025
Q3
$111M Buy
709,087
+140,334
+25% +$21.7M 0.34% 75
2025
Q2
$95.6M Sell
568,753
-100,616
-15% -$14.9M 0.34% 85
2025
Q1
$92.2M Buy
+669,369
New +$85.3M 0.37% 75
2021
Q3
Sell
-46,444
Closed -$2.65M 691
2021
Q2
$2.65M Sell
46,444
-557,154
-92% -$32.6M 0.03% 462
2021
Q1
$36.7M Buy
+603,598
New +$33.3M 0.47% 56
2020
Q3
Sell
-517,016
Closed -$27M 477
2020
Q2
$27M Sell
517,016
-527,016
-50% -$27.2M 0.41% 75
2020
Q1
$50.1M Buy
+1,044,032
New +$54.2M 1% 27

Other funds holding CAH

Alyeska Investment Group's CAH Position: Q2 2026 in Review

Alyeska Investment Group reduced its Cardinal Health (CAH) stake by 98% in Q2 2026, selling an estimated $61.1M and leaving 7,074 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Alyeska Investment Group first reported a position in CAH in Q1 2020 and has held it in 10 quarters since. The position peaked at $111M in Q3 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Alyeska Investment Group held 7,074 shares of Cardinal Health worth $1.68M as of Q2 2026.
  • Alyeska Investment Group sold 294,050 Cardinal Health shares in Q2 2026, an estimated $61.1M.
  • Cardinal Health made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #583 holding.
  • Alyeska Investment Group first reported a position in Cardinal Health in Q1 2020 and has held it in 10 quarters since.
  • Alyeska Investment Group's Cardinal Health position peaked at $111M in Q3 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.